ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 633253 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 633253; 2) Community: the network communities that were significantly associated with the response to NSC 633253; 3) Molecule: the relationships between components within communities and NSC 633253; 4) MDR: the compounds that were significantly associated with the NSC 633253.

NSC Compound Enrichment Correlation
NSC 107658 CYTOCHALASIN B 0.0171490505199913 0.37451954
NSC 639364 2,9-Dimethylellipticinium acetate 0.0171490505199913 0.3539558
NSC 648365 Insulin-Methotrexate conjugate 0.0171490505199913 0.19194358
NSC 652175 2-Pyrazolin-5-one, 1-[(2-hydroxyphenyl)carbonyl]- 3-methyl-4-[(4-nitrophenyl)methylene]- 0.0171490505199913 0.52564715
NSC 668833 Null 0.0171490505199913 0.029061901
NSC 679509 Null 0.0171490505199913 0.52795237
NSC 713201 Null 0.0171490505199913 -0.25006512
NSC 726144 Waol A FD-211 0.0171490505199913 -0.10017343
NSC 762864 Null 0.0171490505199913 0.57500933
NSC 656204 Discorhabdin G 0.0177048892222172 -0.23743773
Total:63  Current:21    [First] [Prev] [Next] [Last]